Einträge von Gogas, Helen auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Anzahl der Einträge: 2.
2023
Chesney, Jason A., Ribas, Antoni, Long, Georgina V.
, Kirkwood, John M.
, Dummer, Reinhard, Puzanov, Igor
, Hoeller, Christoph, Gajewski, Thomas F., Gutzmer, Ralf, Rutkowski, Piotr
, Demidov, Lev, Arenberger, Petr, Shin, Sang Joon, Ferrucci, Pier Francesco, Haydon, Andrew, Hyngstrom, John, van Thienen, Johannes V., Haferkamp, Sebastian
, Guilera, Josep Malvehy, Rapoport, Bernardo Leon
, VanderWalde, Ari, Diede, Scott J.
, Anderson, James R., Treichel, Sheryl, Chan, Edward L., Bhatta, Sumita, Gansert, Jennifer, Hodi, Frank Stephen und Gogas, Helen
(2023)
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.
Journal of Clinical Oncology 41 (3), S. 528-540.
Volltext nicht vorhanden.
, Kirkwood, John M.
, Dummer, Reinhard, Puzanov, Igor
, Hoeller, Christoph, Gajewski, Thomas F., Gutzmer, Ralf, Rutkowski, Piotr
, Demidov, Lev, Arenberger, Petr, Shin, Sang Joon, Ferrucci, Pier Francesco, Haydon, Andrew, Hyngstrom, John, van Thienen, Johannes V., Haferkamp, Sebastian
, Guilera, Josep Malvehy, Rapoport, Bernardo Leon
, VanderWalde, Ari, Diede, Scott J.
, Anderson, James R., Treichel, Sheryl, Chan, Edward L., Bhatta, Sumita, Gansert, Jennifer, Hodi, Frank Stephen und Gogas, Helen
(2023)
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.
Journal of Clinical Oncology 41 (3), S. 528-540.
Volltext nicht vorhanden.
2019
Liu, David, Schilling, Bastian
, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham
, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M. und Schadendorf, Dirk
(2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Nature Medicine 25 (12), S. 1916-1927.
Volltext nicht vorhanden.
, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham
, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M. und Schadendorf, Dirk
(2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Nature Medicine 25 (12), S. 1916-1927.
Volltext nicht vorhanden.
